Rutger Jan Nuis
Erasmus University Rotterdam
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rutger Jan Nuis.
European Heart Journal | 2010
Carl Schultz; Adriaan Moelker; Nicolo Piazza; Apostolos Tzikas; Amber Otten; Rutger Jan Nuis; Lisan A. Neefjes; Robert J. van Geuns; Pim J. de Feyter; Gabriel P. Krestin; Patrick W. Serruys; Peter de Jaegere
AIMS To evaluate the effects of applying current sizing guidelines to different multislice computer tomography (MSCT) aortic annulus measurements on Corevalve (CRS) size selection. METHODS AND RESULTS Multislice computer tomography annulus diameters [minimum: D(min); maximum: D(max); mean: D(mean) = (D(min) + D(max))/2; mean from circumference: D(circ); mean from surface area: D(CSA)] were measured in 75 patients referred for percutaneous valve replacement. Fifty patients subsequently received a CRS (26 mm: n = 22; 29 mm: n = 28). D(min) and D(max) differed substantially [mean difference (95% CI) = 6.5 mm (5.7-7.2), P < 0.001]. If D(min) were used for sizing 26% of 75 patients would be ineligible (annulus too small in 23%, too large in 3%), 48% would receive a 26 mm and 12% a 29 mm CRS. If D(max) were used, 39% would be ineligible (all annuli too large), 4% would receive a 26 mm, and 52% a 29 mm CRS. Using D(mean), D(circ), or D(CSA) most patients would receive a 29 mm CRS and 11, 16, and 9% would be ineligible. In 50 patients who received a CRS operator choice corresponded best with sizing based on D(CSA) and D(mean) (76%, 74%), but undersizing occurred in 20 and 22% of which half were ineligible (annulus too large). CONCLUSION Eligibility varied substantially depending on the sizing criterion. In clinical practice both under- and oversizing were common. Industry guidelines should recognize the oval shape of the aortic annulus.
European Heart Journal | 2014
Ricardo Allende; John G. Webb; Antonio J. Muñoz-García; Peter de Jaegere; Corrado Tamburino; Antonio E. Dager; Asim N. Cheema; Vicenç Serra; Ignacio J. Amat-Santos; James L. Velianou; Marco Barbanti; Danny Dvir; Juan H. Alonso-Briales; Rutger Jan Nuis; Elhamula Faqiri; Sebastiano Immè; Luis Miguel Benitez; Angela Maria Cucalon; Hatim Al Lawati; Bruno García del Blanco; Javier Lopez; Madhu Natarajan; Robert DeLarochellière; Marina Urena; Henrique B. Ribeiro; Eric Dumont; Luis Nombela-Franco; Josep Rodés-Cabau
AIM The aim of this study was to determine the effects of advanced chronic kidney disease (CKD) on early and late outcomes after transcatheter aortic valve implantation (TAVI), and to evaluate the predictive factors of poorer outcomes in such patients. METHODS AND RESULTS This was a multicentre study including a total of 2075 consecutive patients who had undergone TAVI. Patients were grouped according the estimated glomerular filtration rate as follows: CKD stage 1-2 (≥60 mL/min/1.73 m(2); n = 950), stage 3 (30-59 mL/min/1.73 m(2); n = 924), stage 4 (15-29 mL/min/1.73 m(2); n = 134) and stage 5 (<15 mL/min/1.73 m² or dialysis; n = 67). Clinical outcomes were evaluated at 30-days and at follow-up (median of 15 [6-29] months) and defined according to the VARC criteria. Advanced CKD (stage 4-5) was an independent predictor of 30-day major/life-threatening bleeding (P = 0.001) and mortality (P = 0.027), and late overall, cardiovascular and non-cardiovascular mortality (P < 0.01 for all). Pre-existing atrial fibrillation (HR: 2.29, 95% CI: 1.47-3.58, P = 0.001) and dialysis therapy (HR: 1.86, 95% CI: 1.17-2.97, P = 0.009) were the predictors of mortality in advanced CKD patients, with a mortality rate as high as 71% at 1-year follow-up in those patients with these 2 factors. Advanced CKD patients who had survived at 1-year follow-up exhibited both a significant improvement in NYHA class (P < 0.001) and no deterioration in valve hemodynamics (P = NS for changes in mean gradient and valve area over time). CONCLUSIONS Advanced CKD was associated with a higher rate of early and late mortality and bleeding events following TAVI, with AF and dialysis therapy determining a higher risk in these patients. The mortality rate of patients with both factors was unacceptably high and this should be taken into account in the clinical decision-making process in this challenging group of patients.
Catheterization and Cardiovascular Interventions | 2015
Robert M.A. van der Boon; Patrick Houthuizen; Marina Urena; Thomas T. Poels; Nicolas M. Van Mieghem; Guus Brueren; Sibel Altintas; Rutger Jan Nuis; Patrick W. Serruys; Leen van Garsse; Ron T. van Domburg; Joseph Rodes Cabau; Peter de Jaegere; Frits W. Prinzen
The aim of the study was to investigate trends over time in the occurrence of left bundle branch block (LBBB) and permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) with the Medtronic CoreValve System (MCS) and Edwards SAPIEN Valve (ESV). Background: TAVI‐induced conduction abnormalities (TAVI‐CAs) such as LBBB and the need for PPI are frequent postoperative complication. New techniques, procedural refinements, and increased awareness are focused on the reduction of these abnormalities.
Catheterization and Cardiovascular Interventions | 2011
Carl Schultz; Stella-Lida Papadopoulou; Adriaan Moelker; Rutger Jan Nuis; Gert–Jan ten Kate; Nico R. Mollet; Marcel L. Geleijnse; Pim J. de Feyter; Peter de Jaegere; Patrick W. Serruys
To describe a method for the estimation of transaortic flow from multidetector computer tomography (MDCT).
American Heart Journal | 2010
Nicolo Piazza; Peter Wenaweser; Menno van Gameren; Thomas Pilgrim; Apostolos Tsikas; Amber Otten; Rutger Jan Nuis; Yoshinobu Onuma; Jin Ming Cheng; A. Pieter Kappetein; Eric Boersma; Peter Jüni; Peter de Jaegere; Stephan Windecker; Patrick W. Serruys
Netherlands Heart Journal | 2012
Rutger Jan Nuis; Antonio E. Dager; R. M. van der Boon; M. C. Jaimes; Bernardo Caicedo; J. Fonseca; N.M. Van Mieghem; Luis Miguel Benitez; J. P. Umana; William W. O’Neill; E. De Marchena; P. P. de Jaegere
Texas Heart Institute Journal | 2012
Antonio E. Dager; Rutger Jan Nuis; Bernardo Caicedo; Jaime A. Fonseca; Camilo Arana; Lidsa R N Cruz; Luis Miguel Benitez; Carlos A. Nader; Eduardo Duenas; Eduardo de Marchena; William W. O'Neill; Peter de Jaegere
Archive | 2015
Patrick Houthuizen; Marina Urena; Thomas T. Poels; Nicolas M. Van Mieghem; Sibel Altintas; Rutger Jan Nuis; Patrick W. Serruys; Ron T. van Domburg; Joseph Rod; Frits W. Prinzen
Texas Heart Institute Journal | 2013
Rutger Jan Nuis; Luis Miguel Benitez; Carlos A. Nader; Sergio Perez; Eduardo de Marchena; Antonio E. Dager
European Heart Journal | 2013
Rutger Jan Nuis; Jan-Malte Sinning; Josep Rodés-Cabau; M. Gotzmann; L. Van Garsse; Joelle Kefer; Johan Bosmans; Gerald Yong; Antonio E. Dager; A. Revilla-Orodea